Reference health
Performance of a SARS CoV-2 antibody ELISA based on simultaneous measurement of antibodies against the viral nucleoprotein and receptor-binding domain
29/29 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 29 checked references that resolve
resolves10.1016/S0140-6736(20)32137-1
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
resolves10.1080/22221751.2020.1762515
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
resolves10.1093/cid/ciaa344
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
resolves10.1002/14651858.CD013652
Antibody tests for identification of current and past infection with SARS-CoV-2
resolves10.1016/j.ijid.2020.10.011
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review
resolves10.1016/S0140-6736(20)31483-5
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
resolves10.3390/jcm9113752
An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens
resolves10.1016/j.clinbiochem.2020.08.009
High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies
resolves10.1016/j.jviromet.2020.114047
Comparative evaluation of six immunoassays for the detection of antibodies against SARS-CoV-2
resolves10.1093/clinchem/hvaa122
Molecular and Serological Assays for SARS-CoV-2: Insights from Genome and Clinical Characteristics
resolves10.3390/microorganisms8101572
Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection
resolves10.1016/j.jcv.2020.104613
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody
resolves10.1016/j.jcv.2020.104569
Comparison of different serological assays for SARS-CoV-2 in real life
resolves10.1128/JCM.00461-20
Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
resolves10.1016/j.jcv.2020.104544
Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests
resolves10.1128/JCM.01243-20
Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
resolves10.1097/TP.0000000000003524
Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins
resolves10.1038/s41467-021-21040-7
A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
resolves10.1016/j.jviromet.2020.114025
Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay
resolves10.1007/s10096-021-04220-7
Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples
resolves10.1016/j.jcv.2020.104394
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
resolves10.1007/s15010-020-01503-7
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization
resolves10.1126/science.abf4063
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
resolves10.1126/sciimmunol.abe0367
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
resolves10.1016/j.cell.2020.11.029
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
The 1 reference without a DOI — listed, not checked
no DOI — not checkedAnand S, Montez-Rath M, Han J et al (2020) Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32009-2/fulltext
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1007/s10096-021-04284-5"><img src="https://citestamp.com/citestamped/10.1007/s10096-021-04284-5/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1007/s10096-021-04284-5)